Teijin Limited (TSE:3401) agreed to acquire 86% stake in the medical business from Takiron Co.,Ltd. (TSE:4215) for ¥1.63 billion on January 24, 2017. Teijin Limited will rename the buisness as Teijin Medical Technologies Co., Ltd. Takiron Co.,Ltd. will retain 14% stake in Teijin Medical Technologies Co., Ltd. after the close of the transaction. A formal agreement for the share acquisition will be signed on January 24, 2017 and the transaction is expected to complete on July 3, 2017.

Teijin Limited (TSE:3401) completed the acquisition of 86% stake in the medical business from Takiron Co.,Ltd. (TSE:4215) on July 3, 2017.